DrugPatentWatch Database Preview
Bionpharma Inc Company Profile
What is the competitive landscape for BIONPHARMA INC, and what generic alternatives to BIONPHARMA INC drugs are available?
BIONPHARMA INC has twenty-two approved drugs.
There are five US patents protecting BIONPHARMA INC drugs.
Summary for Bionpharma Inc
| US Patents: | 5 |
| Tradenames: | 23 |
| Ingredients: | 20 |
| NDAs: | 22 |
| Drug Master File Entries: | 2 |
| Patent Litigation for Bionpharma Inc: | See patent lawsuits for Bionpharma Inc |
Drugs and US Patents for Bionpharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bionpharma Inc | STAVZOR | valproic acid | CAPSULE, DELAYED RELEASE;ORAL | 022152-003 | Jul 29, 2008 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Bionpharma Inc | STAVZOR | valproic acid | CAPSULE, DELAYED RELEASE;ORAL | 022152-002 | Jul 29, 2008 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Bionpharma Inc | NAPROXEN SODIUM | naproxen sodium | CAPSULE;ORAL | 021920-001 | Feb 17, 2006 | OTC | Yes | Yes | 10,028,925 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Bionpharma Inc | DOFETILIDE | dofetilide | CAPSULE;ORAL | 208625-003 | Apr 10, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Bionpharma Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET;ORAL | 209753-001 | Mar 2, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Bionpharma Inc | VALPROIC ACID | valproic acid | CAPSULE;ORAL | 073484-001 | Jun 29, 1993 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Bionpharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bionpharma Inc | MIDOL LIQUID GELS | ibuprofen | CAPSULE;ORAL | 021472-001 | Oct 18, 2002 | 6,251,426 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for Bionpharma Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| China | 101166520 | ➤ Sign Up |
| Germany | 60034044 | ➤ Sign Up |
| Portugal | 1863458 | ➤ Sign Up |
| Japan | 2003508434 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 2006096580 | ➤ Sign Up |
| European Patent Office | 1207872 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Bionpharma Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 00C/005 | Belgium | ➤ Sign Up | PRODUCT NAME: DOFETILIDE; REGISTRATION NO/DATE: EU/1/99/121/001 19991129 |
| C/GB00/005 | United Kingdom | ➤ Sign Up | PRODUCT NAME: DOFETILIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/99/121/001 19991129; UK EU/1/99/121/002 19991129; UK EU/1/99/121/003 19991129; UK EU/1/99/121/004 19991129; UK EU/1/99/121/005 19991129; UK EU/1/99/121/006 19991129; UK EU/1/99/121/007 19991129; UK EU/1/99/121/008 19991129; UK EU/1/99/121/009 19991129; UK EU/1/99/121/010 19991129; UK EU/1/99/121/011 19991129; UK EU/1/99/121/012 19991129; UK EU/1/99/121/013 19991129; UK EU/1/99/121/014 19991129; UK EU/1/99/121/015 19991129 |
| C/GB04/003 | United Kingdom | ➤ Sign Up | PRODUCT NAME: PARICALCITOL; REGISTERED: ES SPAIN 64.974 20020809; UK PL 00037/0403 20030721 |
| C0027 | France | ➤ Sign Up | PRODUCT NAME: BEXAROTENE; REGISTRATION NO/DATE: EU/1/01/178/001 20010329 |
| 00085 | Netherlands | ➤ Sign Up | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
| 2012000051 | Germany | ➤ Sign Up | PRODUCT NAME: KOMBINATIONSPRODUKT UMFASSEND NAPROXEN UND ESOMEPRAZOL-MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 85145.00.00 20120202; FIRST REGISTRATION: GROSSBRITANNIEN PL 17901/0263 - 0001 20101105 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
